Biolife Solutions INC Form 4 insider transactions

BioLife Solutions Director Joydeep Goswami sold 1,666 shares of common stock for $28.99 per share under a pre-arranged 10b5-1 trading plan.

BioLife Solutions President and CEO, Roderick de Greef, sold 37,795 shares of common stock at $27.3 per share to cover tax withholding obligations.

BioLife Solutions' Chief Technology Officer, Sean Werner, sold 275 shares of common stock at $27.82 per share to cover tax withholding obligations.

Joydeep Goswami, a Director at BioLife Solutions Inc., sold 1,334 shares of common stock on October 16, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Casdin Partners Master Fund, a significant shareholder and director of BioLife Solutions Inc., divested 750,000 shares of common stock for approximately $21.4 million.

BioLife Solutions' Chief Financial Officer, Troy Wichterman, sold 833 shares of common stock for tax withholding obligations under a pre-arranged trading plan.

BioLife Solutions' Chief Marketing Officer, Todd Berard, sold 289 shares of common stock for $27.36 per share to cover tax withholding obligations related to restricted stock vesting.

BioLife Solutions' EVP & Chief Scientific Officer, Aby J. Mathew, sold 509 shares of common stock for $27.36 each to cover tax withholding obligations.

BioLife Solutions' Chief Human Resources Officer, Sarah Aebersold, sold 188 shares of common stock at $27.36 per share to cover tax withholding obligations.

Karen A. Foster, Chief Quality and Operations at BioLife Solutions, sold 419 shares of common stock to cover tax withholding obligations.

Sarah Aebersold, Chief Human Resources Officer at BioLife Solutions Inc., sold 714 shares of common stock for $25.61 per share on September 15, 2025, as part of a Rule 10b5-1 trading plan.

Karen A. Foster, Chief Quality and Operations at BioLife Solutions, sold 511 shares of common stock for $26.83 per share to cover tax withholding obligations.

BioLife Solutions' EVP & Chief Scientific Officer, Aby J. Mathew, sold 630 shares of common stock for $26.83 per share to cover tax withholding obligations.

BioLife Solutions' CFO, Troy Wichterman, sold 1,032 shares of common stock at $26.83 per share to cover tax withholding obligations from restricted stock vesting.

BioLife Solutions Chief Marketing Officer Todd Berard sold 358 shares of common stock on September 11, 2025, to cover tax withholding obligations.

BioLife Solutions' Chief Human Resources Officer, Sarah Aebersold, sold 233 shares of common stock for $26.83 per share to cover tax withholding obligations.

BioLife Solutions' Chief Technology Officer, Sean Werner, sold 72 shares of common stock at $26.83 per share to cover tax withholding obligations.

BioLife Solutions EVP & Chief Scientific Officer, Aby J. Mathew, sold 531 shares of common stock at $25.44 per share to cover tax withholding obligations.

BioLife Solutions' Chief Quality and Operations Officer, Karen A. Foster, sold 413 shares of common stock for tax withholding purposes.

BIOLIFE SOLUTIONS Chief Technology Officer, Sean Werner, sold 111 shares of common stock to cover tax withholding obligations.

BioLife Solutions CFO Troy Wichterman sold 590 shares of common stock for tax obligations under a pre-arranged 10b5-1 plan.

BioLife Solutions' Chief Human Resources Officer, Sarah Aebersold, sold 219 shares of common stock for tax withholding purposes.

BioLife Solutions' Chief Marketing Officer, Todd Berard, sold 354 shares of common stock to cover tax withholding obligations.

BioLife Solutions' Chief Marketing Officer, Todd Berard, sold 10,000 shares of common stock for approximately $25.53 per share in a pre-planned transaction.

Casdin Partners Master Fund, a 10% owner and director, sold 500,000 shares of BioLife Solutions Inc. common stock for $24.40 per share.

Casdin Partners Master Fund, a 10% owner and director, plans to sell 500,000 shares of BioLife Solutions common stock at $22.6 per share on August 11, 2025, under a Rule 10b5-1 plan.

BioLife Solutions Chief Technology Officer Sean Werner sold 1,115 shares of common stock for $21.22 per share to satisfy tax withholding obligations under a pre-arranged trading plan.

BioLife Solutions' Chief Human Resources Officer, Sarah Aebersold, sold 198 shares of common stock on July 7, 2025, at $22.27 per share to cover tax withholding obligations.

Karen A. Foster, Chief Quality and Operations at BioLife Solutions Inc., sold 400 shares of common stock for $22.27 per share on July 7, 2025, as part of a pre-arranged Rule 10b5-1 trading plan to cover tax obligations.

BioLife Solutions' Chief Financial Officer, Troy Wichterman, sold 877 shares of common stock on July 7, 2025, at $22.27 per share, as part of a pre-arranged 10b5-1 plan to satisfy tax withholding obligations.